Patents by Inventor Charlene Mello

Charlene Mello has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9551666
    Abstract: Reactive and modified M13 bacteriophages, and methods of making and using the same, are generally provided. The reactive M13 bacteriophage can include a alkyne functional group covalently attached to the M13 bacteriophage. The modified M13 bacteriophage can include a substituent covalently attached to the M13 bacteriophage via a 1,2,3-triazole linkage. Dual-modified M13 bacteriophages are also generally provided, and can include a cancer-targeting substituent covalently attached to the M13 bacteriophage and a fluorescent group covalently attached to the M13 bacteriophage. The modified M13 bacteriophages can not only be employed as a fluorescent probe for cancer imaging, but also can be used as biomaterials for cell alignment and scaffolding.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: January 24, 2017
    Assignee: University of South Carolina
    Inventors: Qian Wang, Kai Li, Charlene Mello
  • Publication number: 20130337435
    Abstract: Reactive and modified M13 bacteriophages, and methods of making and using the same, are generally provided. The reactive M13 bacteriophage can include a alkyne functional group covalently attached to the M13 bacteriophage. The modified M13 bacteriophage can include a substituent covalently attached to the M13 bacteriophage via a 1,2,3-triazole linkage. Dual-modified M13 bacteriophages are also generally provided, and can include a cancer-targeting substituent covalently attached to the M13 bacteriophage and a fluorescent group covalently attached to the M13 bacteriophage. The modified M13 bacteriophages can not only be employed as a fluorescent probe for cancer imaging, but also can be used as biomaterials for cell alignment and scaffolding.
    Type: Application
    Filed: March 13, 2013
    Publication date: December 19, 2013
    Inventors: Qian Wang, Kai Li, Charlene Mello
  • Patent number: 8415131
    Abstract: Reactive and modified M13 bacteriophages, and methods of making and using the same, are generally provided. The reactive M13 bacteriophage can include a alkyne functional group covalently attached to the M13 bacteriophage. The modified M13 bacteriophage can include a substituent covalently attached to the M13 bacteriophage via a 1,2,3-triazole linkage. Dual-modified M13 bacteriophages are also generally provided, and can include a cancer-targeting substituent covalently attached to the M13 bacteriophage and a fluorescent group covalently attached to the M13 bacteriophage. The modified M13 bacteriophages can not only be employed as a fluorescent probe for cancer imaging, but also can be used as biomaterials for cell alignment and scaffolding.
    Type: Grant
    Filed: October 23, 2009
    Date of Patent: April 9, 2013
    Assignee: University of South Carolina
    Inventors: Qian Wang, Kai Li, Charlene Mello
  • Publication number: 20100190233
    Abstract: Reactive and modified M13 bacteriophages, and methods of making and using the same, are generally provided. The reactive M13 bacteriophage can include a alkyne functional group covalently attached to the M13 bacteriophage. The modified M13 bacteriophage can include a substituent covalently attached to the M13 bacteriophage via a 1,2,3-triazole linkage. Dual-modified M13 bacteriophages are also generally provided, and can include a cancer-targeting substituent covalently attached to the M13 bacteriophage and a fluorescent group covalently attached to the M13 bacteriophage. The modified M13 bacteriophages can not only be employed as a fluorescent probe for cancer imaging, but also can be used as biomaterials for cell alignment and scaffolding.
    Type: Application
    Filed: October 23, 2009
    Publication date: July 29, 2010
    Applicant: UNIVERSITY OF SOUTH CAROLINA
    Inventors: Qian Wang, Kai Li, Charlene Mello
  • Patent number: 7335739
    Abstract: Methods are described for the purification and spinning of recombinant and non-recombinant proteins. Specifically, the lysis of bacteria and purification of silk proteins occur in a single solution of organic acid. Bacterial proteins are hydrolyzed while the silk protein remains intact. Silk proteins remain soluble as they are concentrated into a aqueous-based mixture for fiber spinning.
    Type: Grant
    Filed: April 29, 2003
    Date of Patent: February 26, 2008
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Charlene Mello, Steven Arcidiacono, Michelle M. Butler
  • Publication number: 20070231833
    Abstract: Labeled antimicrobial peptides and method of using the same to detect a microorganism of interest. In one embodiment, the method involves adding immuno-capture beads to a sample, the immuno-capture beads including capture antibodies coupled to a paramagnetic bead, the capture antibodies being specific for the type of microorganism of interest. After mixing, the target microorganism binds to the capture antibodies. Next, the beads are collected by positioning a magnet close to the sample, and the unbound material is removed from the sample. Then, a solution containing fluorescently-labeled antimicrobial peptide is added to the sample, the labeled peptide binding in great numbers to the immuno-captured microorganism. After removing unbound peptide, the beads are suspended in solution and a magnetic probe is used to collect the beads in a small volume. With the beads thus drawn together, the solution is excited with a laser. Such excitation causes the label to fluoresce, which fluorescence is then detected.
    Type: Application
    Filed: May 23, 2005
    Publication date: October 4, 2007
    Inventors: Steven Arcidiacono, Charlene Mello, Philip Pivarnik, Andre Senecal
  • Publication number: 20060148066
    Abstract: A membrane assembly adapted for use in capturing an analyte of interest, the membrane assembly comprising in one embodiment (a) an electrospun nanofibrous membrane, the electrospun nanofibrous membrane comprising a random mat of electrospun nanofibers, at least some of the electrospun nanofibers including one or more types of functional groups; and (b) at least one molecular recognition element immobilized on the random mat via a functional group, the molecular recognition element being adapted to selectively bind the analyte of interest. The membrane assembly may be incorporated into a sensor.
    Type: Application
    Filed: January 5, 2005
    Publication date: July 6, 2006
    Inventors: Kris Senecal, Andre Senecal, Philip Pivarnik, Charlene Mello, Jason Soares, Heidi Schreuder-Gibson
  • Publication number: 20050158821
    Abstract: Methods are described for the purification and spinning of recombinant and non-recombinant proteins. Specifically, the lysis of bacteria and purification of silk proteins occur in a single solution of organic acid. Bacterial proteins are hydrolyzed while the silk protein remains intact. Silk proteins remain soluble as they are concentrated into a aqueous-based mixture for fiber spinning.
    Type: Application
    Filed: April 29, 2003
    Publication date: July 21, 2005
    Inventors: Charlene Mello, Steven Arcidiacono, Michelle Butler
  • Patent number: 6753454
    Abstract: A novel fiber comprising a substantially homogeneous mixture of a hydrophilic polymer and a polymer which is at least weakly hydrophobic is disclosed. The fiber optionally contains a pH adjusting compound. A method of making the fiber comprises electrospinning fibers of the substantially homogeneous polymer solution. A method of treating a wound or other area of a patient requiring protection from contamination comprises electrospinning the substantially homogeneous polymer solution to form a dressing. An apparatus for electrospinning a wound dressing is discosed.
    Type: Grant
    Filed: May 16, 2000
    Date of Patent: June 22, 2004
    Assignee: The University of Akron
    Inventors: Daniel J. Smith, Darrell H. Reneker, Albert T. McManus, Heidi L. Schreuder-Gibson, Charlene Mello, Michael S. Sennett
  • Patent number: 6620917
    Abstract: Methods are described for the purification and spinning of recombinant and non-recombinant proteins. Specifically, the lysis of bacteria and purification of silk proteins occur in a single solution of organic acid. Bacterial proteins are hydrolyzed while the silk protein remains intact. Silk proteins remain soluble as they are concentrated into a aqueous-based mixture for fiber spinning.
    Type: Grant
    Filed: January 20, 2000
    Date of Patent: September 16, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Charlene Mello, Steven Arcidiacono, Michelle M. Butler
  • Patent number: 6287844
    Abstract: Compositions and methods for the control of genetically engineered organisms are described. A more effective cell suicide approach is contemplated based on the conditional expression of the lethal Streptomyces avidinii streptavidin gene. Toxicity of streptavidin is derived from its exceptionally high binding affinity for an essential prosthetic group, D-biotin. The general requirement for biotin through the living world makes streptavidin-based conditional lethal designs applicable to a broad range of containment strategies.
    Type: Grant
    Filed: February 6, 1998
    Date of Patent: September 11, 2001
    Assignees: The Trustees of Boston University, The United States of America as represented by the Secretary of the Army
    Inventors: Przemyslaw Szafranski, Charlene Mello, Takeshi Sano, Cassandra L. Smith, David L. Kaplan, Charles R. Cantor
  • Patent number: 6124129
    Abstract: Compositions and methods for the control of genetically engineered organisms are described. A more effective cell suicide approach is contemplated based on the conditional expression of the lethal Streptomyces avidinii streptavidin gene. Toxicity of streptavidin is derived from its exceptionally high binding affinity for an essential prosthetic group, D-biotin. The general requirement for biotin through the living world makes streptavidin-based conditional lethal designs applicable to a broad range of containment strategies.
    Type: Grant
    Filed: February 6, 1998
    Date of Patent: September 26, 2000
    Assignee: The Trustees of Boston University
    Inventors: Przemyslaw Szafranski, Charlene Mello, Takeshi Sano, Cassandra L. Smith, David L. Kaplan, Charles R. Cantor